Hercules Capital, INC

Hercules Capital announces record Q2 2026 financial results with significant year-over-year growth in investment income and net investment income, alongside strong origination and funding volumes.

Hercules Capital, Inc. has entered into an Eleventh Supplemental Indenture to issue $325 million in aggregate principal amount of 6.300% Notes due 2031.

Hercules Capital reports preliminary Q2 2026 results, showing an increase in Net Asset Value per share and significant new investment commitments.

Hercules Capital, Inc. announced the results of its 2026 Annual Meeting of Stockholders, with all proposals, including director election and compensation votes, receiving stockholder approval.

Hercules Capital announced record first quarter 2026 financial results, with total new debt and equity commitments reaching $1.81 billion, a 77.8% year-over-year increase.

Hercules Capital, Inc. has announced a strategic evolution of its executive leadership team, promoting Seth Meyer to President and appointing Andrew Olson as Chief Financial Officer and Head of Corporate Development, effective May 18, 2026.

Hercules Capital, Inc. (HTGC) reported a robust Q2 2026, with total investment income reaching $149.1 million and net investment income at $92.9 million, driven by a growing debt investment portfolio.

Hercules Capital, Inc. reported increased net investment income and net asset value per share for the nine months ended September 30, 2025, despite significant net realized losses.

Hercules Capital, Inc. reported a significant increase in total investment income and net assets for the six months ended June 30, 2025, driven by portfolio growth and strategic financing activities, despite a net realized loss.

Hercules Capital's Q1 2025 results show a robust investment portfolio valued at $3.9 billion, despite a net decrease in net assets resulting from operations.

Hercules Capital's Q3 2024 filing details a diverse investment portfolio across various sectors, including biotechnology, software, and healthcare.

Hercules Capital's 10-Q filing details its investment portfolio as of June 30, 2024, including debt and equity investments across various sectors.

Hercules Capital, Inc. reported a robust financial performance for the fiscal year ended December 31, 2025, driven by increased investment income and strategic portfolio expansion.

Hercules Capital's annual report reveals a robust investment portfolio exceeding $3.6 billion, highlighting its position as a key player in technology and life sciences financing.

Hercules Capital, Inc. details its registered securities, capital stock, and corporate governance practices in its annual 10-K filing.

Christian Follmann, Chief Operating Officer of Hercules Capital, Inc., reported multiple transactions in common stock on July 9, 2026.

Seth H Meyer, President of Hercules Capital, Inc., reported multiple transactions in common stock on July 9, 2026.

Scott Bluestein, Chief Executive Officer and a Director of Hercules Capital, Inc., reported multiple transactions in common stock on July 9, 2026.

Kiersten Zaza Botelho, Chief Legal Officer & CCO of Hercules Capital, Inc., reported multiple transactions in common stock on July 9, 2026.

CFO Seth H. Meyer disposed of 5 shares of Hercules Capital common stock to satisfy tax obligations related to restricted stock vesting.

Kiersten Zaza Botelho, Chief Legal Officer & CCO of Hercules Capital, Inc., reported a transaction involving the sale of 1,974 shares of common stock.

Hercules Capital announces its 2026 Annual Meeting of Stockholders, scheduled for June 18, 2026, to elect a director, vote on executive compensation, and approve amendments to equity incentive plans.

Hercules Capital is urging stockholders to vote on proposals including director elections, executive compensation, stock issuance flexibility, and auditor ratification at the virtual annual meeting on June 18, 2025.

Hercules Capital is asking stockholders to vote on key proposals at its annual meeting, including the election of directors, executive compensation, and authorization to sell shares below net asset value (NAV).

Hercules Capital is asking stockholders to approve the authorization to sell or issue shares of its common stock at a price below its net asset value (NAV) per share, subject to certain conditions, at the upcoming annual meeting on June 20, 2024.

Truist Financial Corporation has filed an amended Schedule 13G, disclosing a 0.34% beneficial ownership stake in Hercules Capital, Inc.'s Domestic Preferreds, correcting a prior omission from 2021.